0000950170-24-101059.txt : 20240827 0000950170-24-101059.hdr.sgml : 20240827 20240827164919 ACCESSION NUMBER: 0000950170-24-101059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240823 FILED AS OF DATE: 20240827 DATE AS OF CHANGE: 20240827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelish Henry E. CENTRAL INDEX KEY: 0002029477 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 241249797 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0508 4 2024-08-23 0001861560 Nuvalent, Inc. NUVL 0002029477 Pelish Henry E. C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 false true false false Chief Scientific Officer true Class A Common Stock 2024-08-23 4 S false 10500 85.08 D 66095 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.30, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. /s/ Nathan N. McConarty, attorney-in-fact 2024-08-27